Gelteq Ltd
Research Gelteq Ltd (GELS) on Bullrun: market cap USD 5.87M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGELS
- ExchangeNASDAQ
- CountryAustralia
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 5.87M
- Financial periodQ4 2025
Valuation Snapshot
latest market cap is USD 5.87M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 5.87M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 8.57M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 22.39M | n/a | n/a | n/a |
About Gelteq Ltd
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Gelteq Ltd's market cap?
Gelteq Ltd's market capitalization is USD 5.87M.
What does Gelteq Ltd do?
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.